These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33854064)

  • 21. Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
    Knecht H; Neulinger SC; Heinsen FA; Knecht C; Schilhabel A; Schmitz RA; Zimmermann A; dos Santos VM; Ferrer M; Rosenstiel PC; Schreiber S; Friedrichs AK; Ott SJ
    PLoS One; 2014; 9(2):e89417. PubMed ID: 24586762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection.
    Brown KA; Khanafer N; Daneman N; Fisman DN
    Antimicrob Agents Chemother; 2013 May; 57(5):2326-32. PubMed ID: 23478961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the diagnosis and treatment of Clostridium difficile infections.
    Peng Z; Ling L; Stratton CW; Li C; Polage CR; Wu B; Tang YW
    Emerg Microbes Infect; 2018 Feb; 7(1):15. PubMed ID: 29434201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
    Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
    Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality in clostridioides difficile infection among patients hospitalized at the university clinical hospital in Wroclaw, Poland - a 3-year observational study.
    Drobnik J; Pobrotyn P; Belovičová M; Madziarska K; Trocha M; Baran M
    BMC Infect Dis; 2024 Jun; 24(1):625. PubMed ID: 38910242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The microbial diversity following antibiotic treatment of Clostridioides difficile infection.
    Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A
    BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China.
    Zhou FF; Wu S; Klena JD; Huang HH
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1773-9. PubMed ID: 24820293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes.
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Nguyen A; Asch J; Hoda D
    Clin Transplant; 2019 Nov; 33(11):e13712. PubMed ID: 31532030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.
    Krutova M; Capek V; Nycova E; Vojackova S; Balejova M; Geigerova L; Tejkalova R; Havlinova L; Vagnerova I; Cermak P; Ryskova L; Jezek P; Zamazalova D; Vesela D; Kucharova A; Nemcova D; Curdova M; Nyc O; Drevinek P
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):98. PubMed ID: 32605598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
    Tomkovich S; Stough JMA; Bishop L; Schloss PD
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridioides difficile carriage in animals and the associated changes in the host fecal microbiota.
    Thanissery R; McLaren MR; Rivera A; Reed AD; Betrapally NS; Burdette T; Winston JA; Jacob M; Callahan BJ; Theriot CM
    Anaerobe; 2020 Dec; 66():102279. PubMed ID: 33022384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy.
    Mehta SR; Yen EF
    Transl Res; 2021 Apr; 230():197-207. PubMed ID: 33278650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals.
    Le Monnier A; Candela T; Mizrahi A; Bille E; Bourgeois-Nicolaos N; Cattoir V; Farfour E; Grall I; Lecointe D; Limelette A; Marcade G; Poilane I; Poupy P; Kansau I; Zahar JR; Pilmis B;
    J Hosp Infect; 2022 Nov; 129():65-74. PubMed ID: 35640734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.
    Gonzales-Luna AJ; Spinler JK; Oezguen N; Khan MAW; Danhof HA; Endres BT; Alam MJ; Begum K; Lancaster C; Costa GP; Savidge TC; Hurdle JG; Britton R; Garey KW
    Anaerobe; 2021 Aug; 70():102387. PubMed ID: 34044101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile infection in an endemic setting in the Netherlands.
    Hensgens MP; Goorhuis A; van Kinschot CM; Crobach MJ; Harmanus C; Kuijper EJ
    Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):587-93. PubMed ID: 21194003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China.
    Dai W; Yang T; Yan L; Niu S; Zhang C; Sun J; Wang Z; Xia Y
    BMC Infect Dis; 2020 Apr; 20(1):277. PubMed ID: 32293302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.